Bevacizumab in combination with cetuximab and irinotecan (BCI) after failure of cetuximab and irinotecan (CI) in patients with metastatic colorectal cancer (mCRC)

K Skougaard, Dorte Nielsen, Per Pfeiffer, Trine Lembrecht Jørgensen, Jon Kroll Bjerregaard, Benny Vittrup Jensen

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskning

OriginalsprogEngelsk
Publikationsdato2009
StatusUdgivet - 2009
Begivenhed2009 ASCO Gastrointestinal Cancers Symposium - San Francisco, USA
Varighed: 15. jan. 200917. jan. 2009

Konference

Konference2009 ASCO Gastrointestinal Cancers Symposium
Land/OmrådeUSA
BySan Francisco
Periode15/01/200917/01/2009

Citationsformater